Primary objective
- To unleash next generation in vitro human organoid models for multi-organ interactions in disease -using Cancer Cachexia (CC) as an exemplar of a multi-organ disease.
Project leader: Dr. Tor Erik Rusten Center for Cancer Cell Reprogramming (CanCell), Faculty of Medicine, UiO
Principal investigators:
- Dr. Gareth Sullivan Hybrid Technology Hub, Centre for Organ on a Chip Technology, UiO, and Dpt. of Pediatrics, Oslo University Hospital
- Anne Kjersti Befring Associate professor, Dpt. of Public and International Law, The Faculty of Law, UiO
-
Dr. Yoshiaki Tanaka Assistant professor, Immunology, Faculty of Medicine, University of Montreal, Canada
Read more about MORGI here